Literature DB >> 17465196

Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix.

Paul J Hauser1, Zhiyong Han, Puneet Sindhwani, Robert E Hurst.   

Abstract

Because the response of cancer cells to chemotherapeutic agents depends upon the supporting extracellular matrix (ECM), the response in vivo may not be reproduced in 2-dimensional cell culture. The dose-response to curcumin and two derivatives by bladder cancer cells grown on both normal (SISgel) and cancer-derived ECM (Matrigel) and on plastic were contrasted. Cells grown on Matrigel were resistant to curcumins, but cells growing on SISgel, which mimic cancer cells suppressed by normal ECM, were nearly as sensitive as cells grown on plastic. SV40-immortalized urothelial cells, which are models for premalignant cells, were the most sensitive, but even aggressive cell lines were nearly as sensitive when grown on SISgel as on plastic. Curcumin response depends highly on the supporting ECM, and cells grown on plastic poorly models cells growing on natural ECM. Curcumin could prove an effective chemopreventive for bladder cancer recurrence when administered intravesically post-therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465196      PMCID: PMC2604907     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Authors:  A L Cheng; C H Hsu; J K Lin; M M Hsu; Y F Ho; T S Shen; J Y Ko; J T Lin; B R Lin; W Ming-Shiang; H S Yu; S H Jee; G S Chen; T M Chen; C A Chen; M K Lai; Y S Pu; M H Pan; Y J Wang; C C Tsai; C Y Hsieh
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

2.  Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861.

Authors:  G Jakse; R Hall; A Bono; W Höltl; P Carpentier; J P Spaander; A P van der Meijden; R Sylvester
Journal:  Eur Urol       Date:  2001-08       Impact factor: 20.096

3.  Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.

Authors:  P Sindhwani; J A Hampton; M M Baig; R Keck; S H Selman
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

Review 4.  Diagnosis and management of superficial bladder cancer.

Authors:  C L Amling
Journal:  Curr Probl Cancer       Date:  2001 Jul-Aug       Impact factor: 3.187

5.  Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis.

Authors:  J Y Rao; G P Hemstreet; R E Hurst; R B Bonner; P L Jones; K W Min; Y Fradet
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Acquired multicellular-mediated resistance to alkylating agents in cancer.

Authors:  H Kobayashi; S Man; C H Graham; S J Kapitain; B A Teicher; R S Kerbel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 7.  The health economics of bladder cancer: a comprehensive review of the published literature.

Authors:  Marc F Botteman; Chris L Pashos; Alberto Redaelli; Benjamin Laskin; Robert Hauser
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

8.  Matrix-dependent plasticity of the malignant phenotype of bladder cancer cells.

Authors:  Robert E Hurst; Kimberly D Kyker; Rebecca B Bonner; Ron D Bowditch; George P Hemstreet
Journal:  Anticancer Res       Date:  2003 Jul-Aug       Impact factor: 2.480

9.  A model for 3-dimensional growth of bladder cancers to investigate cell-matrix interactions.

Authors:  Kimberly D Kyker; Daniel J Culkin; Robert E Hurst
Journal:  Urol Oncol       Date:  2003 Jul-Aug       Impact factor: 3.498

10.  The immortalized UROtsa cell line as a potential cell culture model of human urothelium.

Authors:  M R Rossi; J R Masters; S Park; J H Todd; S H Garrett; M A Sens; S Somji; J Nath; D A Sens
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

View more
  6 in total

Review 1.  Modeling human bladder cancer.

Authors:  Cassandra Ringuette-Goulet; Stéphane Bolduc; Frédéric Pouliot
Journal:  World J Urol       Date:  2018-06-14       Impact factor: 4.226

2.  Liposomal Nanoformulation as a Carrier for Curcumin and pEGCG-Study on Stability and Anticancer Potential.

Authors:  Ludwika Piwowarczyk; Malgorzata Kucinska; Szymon Tomczak; Dariusz T Mlynarczyk; Jaroslaw Piskorz; Tomasz Goslinski; Marek Murias; Anna Jelinska
Journal:  Nanomaterials (Basel)       Date:  2022-04-08       Impact factor: 5.719

Review 3.  The bladder extracellular matrix. Part I: architecture, development and disease.

Authors:  Karen J Aitken; Darius J Bägli
Journal:  Nat Rev Urol       Date:  2009-11       Impact factor: 14.432

4.  Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model.

Authors:  J Falke; J Parkkinen; L Vaahtera; C A Hulsbergen-van de Kaa; E Oosterwijk; J A Witjes
Journal:  Biomed Res Int       Date:  2018-06-10       Impact factor: 3.411

Review 5.  Curcumin May Prevent Basement Membrane Disassembly by Matrix Metalloproteinases and Progression of the Bladder Cancer.

Authors:  Paweł Wroński; Stanisław Wroński; Marcin Kurant; Bartosz Malinowski; Michał Wiciński
Journal:  Nutrients       Date:  2021-12-23       Impact factor: 5.717

6.  Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells.

Authors:  R P Sahu; S Batra; S K Srivastava
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.